Showing 1 - 20 results of 36 for search 'Foster, G', query time: 0.05s
Refine Results
-
1
-
2
-
3
Results of a mixed treatment comparison meta-analysis of nucleoside and nucleotide therapies for HBeAG-positive chronic hepatitis B by Dakin, H, Foster, G, James, E
Published 2008Conference item -
4
Boron and magnesium isotopic composition of seawater by Foster, G, Pogge von Strandmann, P, Rae, J
Published 2010Journal article -
5
-
6
-
7
-
8
Physiologically informed neuromodulation by Wendt, K, Denison, T, Foster, G, Krinke, L, Thomson, A, Wilson, S, Widge, AS
Published 2021Journal article -
9
-
10
-
11
Climate sensitivity on geological timescales controlled by non-linear feedbacks and ocean circulation by Farnsworth, A, Lunt, D, O'Brien, C, Foster, G, Inglis, G, Markwick, P, Pancost, R, Robinson, S
Published 2019Journal article -
12
Palaeogeographic controls on climate and proxy interpretation by Lunt, D, Farnsworth, A, Loptson, C, L Foster, G, Markwick, P, O'Brien, C, Pancost, R, Robinson, S, Wrobel, N
Published 2016Journal article -
13
SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants by Jones, M, Cunningham, M, Wing, P, Desilva, S, Challa, R, Sheri, A, Padmanabhan, S, Iyer, R, Korba, B, Afdhal, N, Foster, G
Published 2017Journal article -
14
HCV genotype-3a T cell immunity: specificity, function and impact of therapy by Humphreys, IS, von Delft, A, Brown, A, Hibbert, L, Collier, J, Foster, G, Rahman, M, Christian, A, Klenerman, P, Barnes, E
Published 2012Journal article -
15
HCV genotype-3a T cell immunity: Specificity, function and impact of therapy by Humphreys, I, Von Delft, A, Brown, A, Hibbert, L, Collier, J, Foster, G, Rahman, M, Christian, A, Klenerman, P, Barnes, E
Published 2012Journal article -
16
HCV genotype-3a T cell immunity: specificity, function and impact of therapy. by Humphreys, I, von Delft, A, Brown, A, Hibbert, L, Collier, J, Foster, G, Rahman, M, Christian, A, Klenerman, P, Barnes, E
Published 2012Journal article -
17
HepFree: Screening migrant patients for viral hepatitis in primary care. A 90,000 patient randomised controlled trial indicates benefits are most obvious in older patients by Flanagan, S, Appleby, V, Gaviria, J, Kunkel, J, Madurasinghe, V, Eldridge, S, Moreea, S, Agarwal, K, Barnes, E, Griffiths, C, Pitt, M, Salmon, A, Foster, G
Published 2018Conference item -
18
-
19
-
20
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis. by Cheung, M, Walker, A, Hudson, B, Verma, S, McLauchlan, J, Mutimer, D, Brown, A, Gelson, W, MacDonald, D, Agarwal, K, Foster, G, Irving, W, Uk, H
Published 2016Journal article